AnalystsCharles DuncanCharles Duncan's Stock Forecasts
AnalystsCharles Duncan
Analyst Ranking
Top 2%
#44 out of 4046 analysts
Average Return
+38.41%
Win Rate
43%27 out of 63
Risk vs Reward
Poor
Good
Charles Duncan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +2,273.26% | $9.50 | $225.46 | 2020-03-17 - 2021-03-17 | Strong Buy |
Cassava Sciences IncSAVA | +390.45% | $9.32 | $45.71 | 2020-10-23 - 2021-10-22 | Strong Buy |
Aimmune Therapeutics IncAIMT | +175.26% | $12.53 | $34.49 | 2020-03-23 - 2020-10-12 | Strong Buy |
Novavax IncNVAX | +169.36% | $64.75 | $174.41 | 2020-06-19 - 2021-06-18 | Strong Buy |
Prevail Therapeutics IncPRVL | +103.54% | $11.30 | $23.00 | 2020-09-11 - 2021-01-21 | Strong Buy |
Charles Duncan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $12.00 | +531.58% | Initiates Coverage On | 3 days ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $41.00 | +45.08% | Initiates Coverage On | 3 days ago |
Vaxart IncVXRT | 2 | Strong Buy | $8.00 | +266.97% | Maintains | a month ago |
Biovie IncBIVI | 1 | Strong Buy | $7.00 | +181.12% | Initiates Coverage On | 2 months ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $64.00 | +43.43% | Maintains | 3 months ago |
Acadia Pharmaceuticals IncACAD | 6 | Strong Buy | $26.00 | +58.92% | Maintains | 3 months ago |
Novavax IncNVAX | 6 | Strong Buy | $168.00 | +823.08% | Maintains | 4 months ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $38.00 | +195.95% | Maintains | 4 months ago |
Harmony Biosciences Holdings IncHRMY | 1 | Strong Buy | $63.00 | +42.24% | Initiates Coverage On | 6 months ago |
Aptinyx IncAPTX | 1 | Strong Buy | $5.00 | +1,258.70% | Maintains | 6 months ago |
Oramed Pharmaceuticals IncORMP | 1 | Strong Buy | $20.00 | +208.64% | Initiates Coverage On | 7 months ago |
Vtv Therapeutics IncVTVT | 2 | Strong Buy | $5.00 | +415.46% | Initiates Coverage On | 7 months ago |
Bionomics LimitedBNOX | 1 | Strong Buy | $52.00 | +729.88% | Initiates Coverage On | 9 months ago |
Cardiol Therapeutics IncCRDL | 1 | Strong Buy | $8.00 | +676.70% | Initiates Coverage On | 9 months ago |
Lucid Diagnostics IncLUCD | 1 | Strong Buy | $21.00 | +1,272.55% | Initiates Coverage On | a year ago |
Prothena Corp Public Ltd CoPRTA | 1 | Strong Buy | $103.00 | N/A | Maintains | a year ago |
Biohaven Pharmaceutical Holding Co LtdBHVN | 4 | Strong Buy | $165.00 | N/A | Maintains | a year ago |
Cybin IncCYBN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | a year ago |
Seelos Therapeutics IncSEEL | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | a year ago |
Clene IncCLNN | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | a year ago |
Ovid Therapeutics IncOVID | 1 | Hold | $4.00 | N/A | Downgrades | a year ago |
Anavex Life Sciences CorpAVXL | 1 | Strong Buy | $25.00 | N/A | Reiterates | 2 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 2 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Inovio Pharmaceuticals IncINO | 5 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $39.00 | N/A | Reiterates | 2 years ago |
Cara Therapeutics IncCARA | 1 | Strong Buy | $34.00 | N/A | Reiterates | 2 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $23.00 | N/A | Reiterates | 2 years ago |
Aimmune Therapeutics IncAIMT | 2 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 2 | Strong Buy | $320.00 | N/A | Reiterates | 3 years ago |
Intra Cellular Therapies IncITCI | 3 | Strong Buy | $47.00 | N/A | Reiterates | 3 years ago |
Catalyst Pharmaceuticals IncCPRX | 1 | Strong Buy | $12.00 | N/A | Reiterates | 3 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $7.00 | N/A | Reiterates | 3 years ago |
Corcept Therapeutics IncCORT | 3 | Hold | $14.00 | N/A | Downgrades | 4 years ago |
Vanda Pharmaceuticals IncVNDA | 1 | Hold | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Acorda Therapeutics IncACOR | 1 | Hold | $32.00 | N/A | Initiates Coverage On | 4 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Altimmune IncALT | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Pdl Biopharma IncPDLI | 1 | Strong Buy | $4.00 | N/A | Reinstates | 6 years ago |
©2022 WallStreetZen
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.